What does CUSIP 816212302 represent in this 13F holders report?

CUSIP 816212302 is the security identifier for RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK in Q2 2024?

57 institutional investors reported RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK for Q2 2024. Use the holders table for investor-level position and value details.

Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

CUSIP: 816212302

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / COMMON STOCK
Shares outstanding: 26,658,100
Total 13F shares: 3,268,033
Share change: +3,259,921
Total reported value: $88,276,427
Price per share: $27.01
Number of holders: 57
Value change: +$88,059,260
Number of buys: 51
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 816212302?
CUSIP 816212302 identifies RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 816212302:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	1,180,043	$23,010,839	—	31 Mar 2024	13F
FMR LLC	13F	Company	— class O/S missing	14,369,071	$9,339,896	—	31 Mar 2024	13F
Artal Group S.A.	13F	Company	— class O/S missing	9,136,635	$5,938,813	—	31 Mar 2024	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	7,253,975	$4,715,083	—	31 Mar 2024	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	6,315,113	$4,104,823	—	31 Mar 2024	13F
Erste Asset Management GmbH	13F	Company	— class O/S missing	3,212,093	$2,088,973	—	31 Mar 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	2,498,949	$1,650,487	—	31 Mar 2024	13F
STATE STREET CORP	13F	Company	— class O/S missing	2,086,840	$1,356,446	—	31 Mar 2024	13F
Peter G. Traber	3/4/5	Chief Medical Officer	— class O/S missing	451,826	$930,762	—	25 Sep 2023	3/4/5
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	1,425,154	$926,350	—	31 Mar 2024	13F
Lloyd P. Johnston	3/4/5	Chief Operations Officer	— mixed-class rows	740,515 mixed-class rows	$922,211	—	04 Jan 2023	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	994,632	$646,511	—	31 Mar 2024	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	935,464	$608,052	—	31 Mar 2024	13F
Aymeric Sallin	3/4/5	Director	— mixed-class rows	406,000 mixed-class rows	$546,800	—	02 Jan 2024	3/4/5
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	— class O/S missing	25,071	$488,889	—	31 Mar 2024	13F
Takashi Kei Kishimoto	3/4/5	Chief Scientific Officer	— class O/S missing	225,316	$464,151	—	30 May 2023	3/4/5
DELPHI FINANCIAL GROUP, INC.	13F	Company	— class O/S missing	660,852	$429,554	—	31 Mar 2024	13F
Kevin Tan	3/4/5	Chief Financial Officer	— mixed-class rows	417,000 mixed-class rows	$427,220	—	03 Jan 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	553,600	$360,000	—	31 Mar 2024	13F
Nuveen Asset Management, LLC	13F	Company	— class O/S missing	490,320	$318,708	—	31 Mar 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	325,308	$211,450	—	31 Mar 2024	13F
Bank of New York Mellon Corp	13F	Company	— class O/S missing	317,322	$206,259	—	31 Mar 2024	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	305,800	$198,770	—	31 Mar 2024	13F
CM Management, LLC	13F	Company	— class O/S missing	305,482	$198,563	—	31 Mar 2024	13F
Invesco Ltd.	13F	Company	— class O/S missing	244,699	$159,054	—	31 Mar 2024	13F
MORGAN STANLEY	13F	Company	— class O/S missing	220,942	$143,612	—	31 Mar 2024	13F
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	190,211	$123,637	—	31 Mar 2024	13F
IRONWOOD INVESTMENT MANAGEMENT LLC	13F	Company	— class O/S missing	176,816	$114,930	—	31 Mar 2024	13F
RHUMBLINE ADVISERS	13F	Company	— class O/S missing	129,883	$84,417	—	31 Mar 2024	13F
BARCLAYS PLC	13F	Company	— class O/S missing	118,953	$77,319	—	31 Mar 2024	13F
UBS Group AG	13F	Company	— class O/S missing	117,426	$76,327	—	31 Mar 2024	13F
Squarepoint Ops LLC	13F	Company	— class O/S missing	108,678	$70,641	—	31 Mar 2024	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	99,532	$64,696	—	31 Mar 2024	13F
Goran Ando	3/4/5	Director	— class O/S missing	75,000	$59,250	—	02 Jan 2023	3/4/5
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	66,554	$44,000	—	31 Mar 2024	13F
DEUTSCHE BANK AG\	13F	Company	— class O/S missing	65,815	$42,780	—	31 Mar 2024	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	— class O/S missing	59,125	$38,431	—	31 Mar 2024	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	— class O/S missing	56,202	$36,531	—	31 Mar 2024	13F
Laurie J. Trustee Hall	13F	Individual	— class O/S missing	52,775	$34,000	—	31 Mar 2024	13F
SG Americas Securities, LLC	13F	Company	— class O/S missing	47,134	$31,000	—	31 Mar 2024	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	— class O/S missing	45,996	$29,897	—	31 Mar 2024	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	45,150	$29,347	—	31 Mar 2024	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	— class O/S missing	45,131	$29,335	—	31 Mar 2024	13F
PRUDENTIAL FINANCIAL INC	13F	Company	— class O/S missing	42,505	$27,628	—	31 Mar 2024	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	40,260	$26,169	—	31 Mar 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	36,096	$23,462	—	31 Mar 2024	13F
ALERUS FINANCIAL NA	13F	Company	— class O/S missing	30,000	$19,500	—	31 Mar 2024	13F
Belpointe Asset Management LLC	13F	Company	— class O/S missing	28,400	$18,460	—	31 Mar 2024	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	— class O/S missing	24,126	$15,682	—	31 Mar 2024	13F
CITIGROUP INC	13F	Company	— class O/S missing	21,824	$14,185	—	31 Mar 2024	13F

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q2 2024

As of 30 Jun 2024, Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,268,033 shares. The largest 10 holders included FMR LLC, BlackRock Inc., JPMORGAN CHASE & CO, Artal Group S.A., MPM BIOIMPACT LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Erste Asset Management GmbH. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 Value $	Q2 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.